AtriCure (ATRC) Shares Outstanding (Weighted Average) (2010 - 2026)

AtriCure (ATRC) has 17 years of Shares Outstanding (Weighted Average) data on file, last reported at $48.3 million in Q1 2026.

• Quarterly Shares Outstanding (Weighted Average) rose 1.99% year-over-year to $48.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $48.3 million (up 1.99% YoY) and the FY2025 annual result came in at $47.8 million, up 1.67% from the prior year.
• Shares Outstanding (Weighted Average) climbed to $48.3 million in Q1 2026 per ATRC's latest filing, from $47.8 million in the prior quarter.
• Across five years, Shares Outstanding (Weighted Average) topped out at $48.3 million in Q1 2026 and bottomed at $45.5 million in Q1 2022.
• The 5-year median for Shares Outstanding (Weighted Average) is $46.7 million (2024), against an average of $46.7 million.
• The widest annual swing landed in 2022, when Shares Outstanding (Weighted Average) rose 2.01%; it then rose 0.96% in 2023.
• Tracing ATRC's Shares Outstanding (Weighted Average) over 5 years: stood at $45.7 million in 2022, then gained by 1.24% to $46.3 million in 2023, then rose by 1.42% to $47.0 million in 2024, then grew by 1.67% to $47.8 million in 2025, then gained by 1.22% to $48.3 million in 2026.
• Per Business Quant, the three latest ATRC Shares Outstanding (Weighted Average) figures stand at $48.3 million (Q1 2026), $47.8 million (Q4 2025), and $47.7 million (Q3 2025).

Peer Comparison